Research tools and consumables stocks report mixed Q1 with revenues beating estimates by 1.3%

Earnings
โดย Yahoo Finance·Read original
Summary · why it matters

The ten research tools and consumables stocks tracked reported mixed first-quarter results, with aggregate revenues beating analysts' consensus estimates by 1.3% and next-quarter revenue guidance coming in 2% above expectations. Mettler-Toledo posted revenues of 947.1 million dollars, up 7.2% year on year and slightly ahead of estimates, though the quarter was mixed overall. Waters Corporation stood out with revenues of 1.27 billion dollars, a 91.5% year-on-year surge that exceeded estimates by 4.5%, and it delivered the biggest analyst estimate beat, highest guidance raise, and fastest revenue growth among its peers. Revvity's revenues of 686.9 million dollars, up 9.3% year on year, missed estimates by 2.6% and it issued full-year guidance below expectations, marking the weakest performance against estimates in the group. Sotera Health Company reported revenues of 280 million dollars, up 10% year on year and beating estimates by 3.6%, while Bruker's revenues of 823.4 million dollars, up 2.7% year on year, topped estimates by 3.4%. Share prices of the group have risen 20.8% on average since the latest earnings results.

Impact on stocks 5

Biotech & Genomic Medicine± Mixed · 5 stocks
Waters Corporation
WAT
▲ PositiveCapitalrelevance

Waters revenues surged 91.5% YoY, beat estimates by 4.5%, and raised guidance

Revvity Inc.
RVTY
▼ NegativeCapitalrelevance

Revvity missed revenue estimates by 2.6% and issued below-consensus guidance